sarscoronaviru
sarscov
recent
identifi
caus
agent
sar
construct
seri
recombin
di
rdi
highli
attenu
vaccinia
strain
express
gene
encod
four
structur
protein
e
n
sarscov
individu
simultan
rdi
elicit
sarscovspecif
serum
igg
antibodi
tcell
respons
vaccin
mice
follow
intranas
subcutan
administr
mice
subcutan
vaccin
rdi
express
protein
without
structur
protein
induc
high
level
serum
neutral
igg
antibodi
demonstr
mark
protect
immun
sarscov
challeng
absenc
mucos
iga
respons
result
indic
potent
immun
respons
elicit
subcutan
inject
rdi
contain
abl
control
mucos
infect
sarscov
thu
replicationdefici
di
construct
hold
promis
develop
safe
potent
sar
vaccin
sever
acut
respiratori
syndrom
sar
becom
prioriti
healthcar
agenc
around
world
given
communic
associ
mortal
potenti
pandem
spread
juli
sar
case
identifi
worldwid
result
death
mortal
rate
world
health
organ
statist
sar
known
result
infect
novel
coronaviru
sarscov
ksiazek
et
al
peiri
et
al
evid
sarscov
etiolog
agent
sar
follow
experiment
infect
macaqu
macaca
fasciculari
fulfil
koch
postul
clinic
manifest
sar
hardli
distinct
common
respiratori
viral
infect
includ
influenza
influenza
epidem
might
occur
simultan
eventu
reemerg
sar
effect
sar
vaccin
urgent
requir
well
sensit
diagnost
test
specif
sar
structur
character
sarscov
character
complet
rna
genom
marra
et
al
rota
et
al
ruan
et
al
provid
us
opportun
develop
sar
vaccin
like
coronavirus
sarscov
plusstrand
rna
viru
genom
encod
replicas
gene
product
structur
protein
ie
spike
envelop
e
membran
nucleocapsid
n
marra
et
al
rota
et
al
protein
thought
involv
receptor
bind
e
protein
role
viral
assembl
protein
import
viru
bud
n
protein
role
viral
rna
packag
review
see
refer
holm
recent
angiotensinconvert
enzym
identifi
cellular
receptor
sarscov
thu
first
step
infect
like
involv
bind
protein
receptor
model
mhv
infect
protein
known
contain
import
virusneutr
epitop
elicit
neutral
antibodi
respons
mice
collin
et
al
therefor
protein
coronaviru
might
manipul
induc
immun
howev
n
protein
also
known
contribut
host
immun
respons
anton
et
al
jackwood
hilt
dna
vaccin
encod
glycoprotein
sarscov
induc
cell
neutral
antibodi
respons
well
protect
immun
mous
model
vaccin
plasmid
express
n
protein
capabl
gener
strong
nspecif
humor
tcellmedi
immun
respons
vaccin
mice
kim
et
al
zhao
et
al
zhu
et
al
addit
nspecif
cell
provid
protect
immun
coronavirus
collisson
et
al
seo
et
al
di
strain
highli
restrict
host
rang
mutant
vaccinia
viru
isol
success
egg
passag
die
vaccinia
strain
author
strain
smallpox
vaccin
actual
use
japan
di
replic
pathogen
mice
guinea
pig
rabbit
furthermor
di
replic
variou
mammalian
cell
line
tagaya
et
al
recent
establish
system
foreign
gene
express
insert
target
gene
strain
express
bacteriophag
polymeras
ii
fulllength
gag
gene
observ
ishii
et
al
thu
demonstr
use
system
present
studi
construct
recombin
vaccinia
viru
di
express
one
sarscov
structur
protein
e
n
combin
e
em
e
n
emn
rdi
vaccin
administ
mice
either
subcutan
intranas
humor
cellular
immun
sarscov
vaccin
mice
analyz
demonstr
replicationdefici
di
construct
express
protein
alon
combin
compon
n
alon
elicit
strong
protect
immun
respons
sarscov
infect
structur
transfer
vector
use
studi
pdissars
pdissarsm
pdissarsn
pdissarss
pdissarsem
pdissarsem
pdissarsemn
summar
fig
express
sarscov
n
protein
chick
embryo
fibroblast
cef
cell
infect
rdissar
detect
western
blot
use
monoclon
antibodi
fig
ohnishi
et
al
purifi
sarscov
virion
use
posit
control
fig
lane
pc
robust
signal
detect
kda
correspond
n
protein
sarscov
predict
genom
size
marra
et
al
rota
et
al
band
approach
kda
like
correspond
protein
known
heavili
glycosyl
fig
result
consist
data
report
xiao
et
al
express
fulllength
glycoprotein
sarscov
strain
cell
demonstr
protein
approach
kda
sd
gel
electrophoresi
concern
protein
smear
band
stack
gel
detect
use
polyclon
antibodi
synthet
peptid
protein
mizutani
et
al
presum
form
larg
oligom
sdsresist
cell
fig
similar
result
mention
analysi
protein
sarscov
infecti
bronchiti
viru
weisz
et
al
subcellular
local
n
protein
analyz
immunofluoresc
stain
cell
infect
rdissarsm
demonstr
protein
primarili
coloc
golgi
marker
fig
consist
result
recent
studi
nal
et
al
individu
express
sarscov
n
protein
could
detect
partial
golgi
apparatu
remain
princip
local
cytoplasm
fig
overexpress
recombin
sarss
glycoprotein
could
detect
partial
golgi
apparatu
also
detect
throughout
cytoplasm
fig
result
indic
cell
infect
rdissar
express
signific
level
sarscov
protein
control
promot
expect
posttransl
process
nal
et
al
et
al
examin
antisarscov
respons
mice
inocul
rdissar
four
mice
group
subcutan
intranas
inocul
three
time
pfu
rdissarsn
rdissarsm
rdissarss
rdissarsem
rdissarsemn
ten
day
final
inocul
vaccin
mice
observ
high
level
antisarscov
igg
antibodi
sera
fig
order
prove
effect
vaccin
next
examin
whether
neutral
antibodi
sarscov
elicit
mice
neutral
antibodi
sarscov
induc
mice
follow
subcutan
intranas
inject
rdissarss
rdissarsem
rdissarsemn
mice
immun
rdissarsn
rdissarsm
result
elisa
data
incorpor
fig
depict
neutral
posit
serum
close
circl
thu
result
consist
other
bisht
et
al
buchholz
et
al
yang
et
al
indic
protein
prerequisit
elicit
suffici
igg
antibodi
respons
neutral
similar
neutral
activ
obtain
mice
receiv
alon
combin
compon
therefor
expect
rdissar
express
emn
protein
combin
could
best
vaccin
candid
among
other
n
respect
purifi
sarscov
virion
use
posit
control
sarscov
protein
detect
use
monoclon
antibodi
n
polyclon
antibodi
detect
bound
antibodi
done
horseradish
peroxidaseconjug
goat
antimous
antirabbit
antibodi
visual
chemiluminesc
b
cef
cell
infect
rdi
construct
express
sarscov
structur
protein
n
respect
detect
sarscov
protein
cell
incub
rabbit
polyclon
antibodi
protein
cell
incub
fitcconjug
goat
antirabbit
igg
analyz
subcellular
local
protein
monoclon
antibodi
golgi
marker
rhodamineconjug
goat
antimous
igg
use
sar
protein
shown
green
golgi
apparatu
shown
red
coloc
occur
shown
yellow
intranas
inocul
rdissar
express
emn
induc
sarscovspecif
iga
nasal
mucosa
high
level
mucos
igg
parallel
serum
igg
mucos
iga
respons
believ
crucial
protect
immun
variou
pathogen
meeusen
et
al
next
examin
mucos
immun
respiratori
tract
mice
inocul
rdissar
either
subcutan
intranas
level
antisarscov
iga
within
nasal
wash
fluid
vaccin
mice
determin
enzymelink
immunosorb
assay
elisa
shown
fig
substanti
level
antisarscov
iga
detect
mice
receiv
intranas
inocul
rdissarsemn
compar
inocul
parent
di
p
level
iga
detect
intranas
rdissarsemnsinocul
mice
similar
observ
follow
intranas
immun
uvinactiv
purifi
sarscov
virion
posit
control
hand
subcutan
inject
form
rdissar
produc
slightli
higher
level
iga
observ
di
inject
control
mice
therefor
result
indic
subcutan
rout
inject
ineffici
especi
mucos
iga
respons
requir
sinc
neutral
activ
nevertheless
detect
nasal
wash
mice
follow
subcutan
immun
data
shown
also
measur
antisarscov
igg
level
nasal
wash
mice
fig
high
level
igg
detect
nasal
wash
mice
follow
nasal
immun
observ
correspond
well
igg
level
serum
fig
similar
trend
observ
mice
follow
subcutan
immun
despit
lower
level
mice
immun
intranas
result
suggest
neutral
igg
antibodi
capabl
reach
mucos
surfac
plasma
level
high
enough
protect
rdissarsimmun
mice
nasal
sarscov
challeng
achiev
without
mucos
iga
respons
level
protect
sarscov
challeng
mice
follow
inocul
rdissar
critic
issu
vaccin
develop
inocul
three
time
pfu
rdissarsn
rdissarsem
rdissarsemn
four
mice
group
either
subcutan
intranas
one
week
final
inocul
mice
challeng
intranas
tissu
cultur
infecti
dose
tcid
sarscov
result
shown
fig
mice
inocul
salin
tcid
ml
sarscov
recov
lung
wash
fluid
day
contrast
titer
sarscov
lung
mice
subcutan
immun
rdissarsem
rdissarsemn
limit
detect
true
mice
intranas
immun
rdissarsemn
wherea
viru
recov
mice
similarli
immun
rdissarsem
taken
consider
rel
low
margin
level
mucos
iga
antibodi
mice
intranas
immun
rdissarsemn
rdissarsem
even
iga
respons
subcutan
rout
describ
suggest
mucos
igg
antibodi
iga
antibodi
like
contribut
protect
immun
especi
mice
simultan
immun
recombin
rdissarsemn
hand
titer
sarscov
lung
wash
fluid
mice
intranas
subcutan
immun
rdissarsn
similar
slightli
lower
titer
neg
control
suggest
intranas
subcutan
administr
rdissarsn
protect
mice
sarscov
challeng
highli
reflect
nonneutr
natur
antisarscov
n
antibodi
although
know
system
neutral
igg
antibodi
sarscov
protein
major
compon
protect
immun
cell
respons
also
import
protect
host
variou
viral
infect
previou
studi
coronavirus
protein
shown
play
import
role
viral
pathogenesi
well
induct
protect
immun
holm
order
assess
abil
rdissar
induc
sarscov
sspecif
cell
cell
axillari
lymph
node
aln
superfici
cervic
lymph
node
cln
spleen
mice
subcutan
immun
rdissarss
di
isol
stimul
vitro
uvinactiv
purifi
sarscov
virion
cultur
supernat
collect
day
later
level
interleukin
il
tumor
necrosi
measur
cell
aln
produc
greatest
cytokin
level
fig
data
shown
surpris
light
subcutan
rout
immun
notabl
mice
immun
rdissarss
produc
high
level
upon
vitro
stimul
uvinactiv
purifi
sarscov
virion
product
inflammatori
cytokin
significantli
elev
cell
aln
rdissarss
immun
mice
vitro
stimul
virion
antigen
howev
product
observ
also
mice
immun
parent
di
without
vitro
stimul
virion
antigen
sinc
cell
lymph
node
mice
produc
cytokin
even
vitro
stimul
virion
antigen
data
shown
possibl
inject
di
induc
mild
local
inflamm
even
viral
prolifer
occur
inject
site
pattern
product
similar
maximum
level
cytokin
aln
cell
rdissarssimmun
mice
ngml
respect
next
analyz
antigen
epitop
sarscovspecif
cell
spleen
carri
enzymelink
immunospot
elispot
analysi
use
four
peptid
correspond
bind
region
protein
select
use
syfpeithi
score
well
overlap
peptid
pool
cover
whole
n
protein
splenic
cell
mice
analyz
follow
intranas
subcutan
immun
potent
vaccin
rdissarsemn
high
level
reactiv
observ
especi
cell
subcutan
immun
mice
fig
zhi
et
al
recent
identifi
cell
epitop
known
nynykyryl
balbc
mice
zhi
et
al
contain
sequenc
thu
cell
like
cell
detect
nspecif
cell
mice
subcutan
intranas
immun
rdissarsn
analyz
elispot
case
ten
peptid
pool
aminoterminu
n
protein
result
pool
peptid
thu
detect
nreactiv
cell
capabl
recogn
first
peptid
pool
fig
observ
greater
proport
nspecif
cell
follow
nasal
immun
subcutan
immun
result
indic
sand
nspecif
cell
gener
system
rdi
order
elucid
whether
sarscovspecif
cell
induc
immun
rdi
splenic
cell
mice
subcutan
intranas
immun
rdissarsemn
analyz
elispot
use
stabli
sexpress
b
cell
clone
antigen
present
cell
apc
express
protein
clone
confirm
fac
analysi
use
antisar
monoclon
antibodi
fig
empti
vector
transfect
use
neg
control
apc
subcutan
intranas
immun
potent
rdissarsemn
gener
signific
level
sspecif
cell
fig
dramat
decreas
sspecif
cell
observ
follow
partial
deplet
cell
fig
therefor
rdissarsemn
abl
induc
sarscovreact
cell
immunogen
rdi
express
sarscov
structur
protein
evalu
histopatholog
immunohistochem
analysi
lung
tissu
mice
primari
infect
site
sarscov
fig
slight
migrat
inflammatori
cell
mild
disrupt
bronchial
epithelium
detect
lung
tissu
mockvaccin
mice
sarscov
antigen
diffus
observ
within
bronchial
alveolar
epithelium
contrast
signific
lymphocyt
infiltr
peribronchi
site
littl
detect
sarscov
antigen
observ
mice
intranas
immun
rdissarsem
rdissarsemn
fig
infiltr
lymphocyt
found
tcell
determin
immunohistochemistri
antibodi
fig
hand
intranas
subcutan
immun
nexpress
di
induc
neither
tcell
infiltr
protect
immun
sarscov
despit
induct
nspecif
antibodi
cell
result
suggest
mark
induct
tcell
respons
mice
immun
rdissarsem
rdissarsemn
help
elimin
sarscov
lung
tissu
hand
intranas
subcutan
immun
nexpress
di
induc
protect
immun
sarscov
despit
di
strain
replic
well
cef
cell
mammalian
cell
isol
die
strain
vaccinia
viru
serial
egg
passag
character
induct
tini
pock
chicken
chorioallanto
membran
tagaya
et
al
kitamura
et
al
ishii
et
al
disderiv
recombin
virus
express
high
level
viral
insert
gene
even
nonpermiss
cell
line
without
cytopath
effect
ishii
et
al
earlier
studi
mva
strain
vaccinia
viru
also
replicationincompet
mammal
cell
use
express
varieti
foreign
gene
recombin
virus
studi
candid
vaccin
vector
appear
effect
mani
replicationcompet
vaccinia
viru
vaccin
sutter
moss
sutter
et
al
belyakov
et
al
nam
et
al
stittelaar
et
al
rdi
replic
produc
infecti
virion
mammalian
cell
therefor
di
strain
safeti
advantag
use
recombin
vaccin
vector
mva
recent
recombin
di
rdissivgag
express
fulllength
gag
gene
siv
develop
demonstr
potenti
use
hivaid
vaccin
someya
et
al
attempt
vaccin
develop
sarscov
ongo
number
organ
use
variou
techniqu
see
review
groneberg
et
al
dna
vaccin
kim
et
al
yang
et
al
zhu
et
al
zhao
et
al
viral
vector
vaccinia
viru
bisht
et
al
weingartl
et
al
parainfluenza
viru
adenoviru
zakhartchouk
et
al
rhabdovirus
faber
et
al
kapadia
et
al
use
recombin
vaccin
yang
et
al
show
viral
replic
reduc
six
order
magnitud
lung
mice
vaccin
plasmid
dna
express
vector
protect
mediat
humor
tcelldepend
immun
mechan
bisht
et
al
show
inocul
balbc
mice
recombin
mva
express
sarscov
protein
elicit
serum
antibodi
sarscov
protein
protect
immun
sarscov
infect
previou
studi
demonstr
passiv
transfer
serum
immun
mice
confer
protect
sarscov
respiratori
tract
follow
inocul
either
sar
cov
recombin
mva
express
protein
bisht
et
al
subbarao
et
al
result
suggest
protein
crucial
antigen
gener
protect
immun
observ
intranas
subcutan
inocul
balbc
mice
rdi
express
protein
rdissarss
rdissarsem
rdissarsem
ns
produc
serum
antibodi
capabl
recogn
sarscov
virion
elisa
also
capabl
neutral
sarscov
vitro
subcutan
rout
appear
elicit
stronger
immun
intranas
immun
respect
level
antisarscov
igg
antibodi
produc
import
find
although
mucos
iga
antibodi
respons
induc
mice
intranas
immun
rdissarsemn
mice
administ
rdissarsemn
either
rout
elicit
strong
protect
immun
therefor
protect
achiev
absenc
mucos
iga
respons
mice
subcutan
immun
rdissarsemn
thu
result
clearli
show
mucos
infect
might
prevent
presenc
high
level
neutral
serum
igg
antibodi
control
mice
vaccin
di
express
envelop
protein
protect
indic
effect
specif
express
envelop
protein
sarscov
due
enhanc
nonspecif
immun
recent
report
suggest
combin
three
adenoviru
vector
express
sarss
n
protein
capabl
elicit
neutral
antibodi
serum
nspecif
cell
respons
rhesu
macaqu
gao
et
al
howev
report
relationship
immun
respons
actual
protect
present
anoth
studi
import
sarscov
structur
protein
gener
protect
immun
investig
express
individu
combin
use
recombin
parainfluenza
viru
piv
type
vector
express
two
put
virion
envelop
protein
e
protein
augment
neutral
antibodi
respons
absenc
express
e
nucleocapsid
protein
n
induc
detect
serum
sarscovneutr
antibodi
respons
result
consist
express
n
protein
administr
di
harbor
sarscov
n
gene
singli
induc
neutral
antibodi
respons
although
antisarscov
antibodi
detect
elisa
recent
studi
shown
vaccin
plasmid
express
n
protein
elicit
sarscov
nucleocapsidspecif
humor
cellular
immun
respons
kim
et
al
zhu
et
al
zhao
et
al
show
linkag
n
protein
calreticulin
ca
bind
protein
known
enhanc
immun
respons
dna
vaccin
result
signific
enhanc
humor
cellular
immun
respons
n
protein
vaccin
mice
also
show
n
proteinspecif
dna
vaccin
elicit
partial
protect
n
protein
express
vaccinia
viru
challeng
howev
efficaci
nspecif
cellular
immun
respons
protect
sarscov
infect
clear
although
show
n
protein
express
rdi
capabl
elicit
nspecif
humor
cellular
immun
vaccin
rdissarsn
fail
elicit
neutral
antibodi
respons
sarscov
infect
vitro
fail
confer
full
protect
vaccin
mice
sarscov
challeng
suggest
sarscov
n
proteinspecif
antibodi
ctl
suffici
provid
full
protect
sarscov
infect
histopatholog
analysi
lung
tissu
present
studi
reveal
mark
lymphocyt
infiltr
peribronchi
site
mice
immun
intranas
subcutan
recombin
vaccinia
viru
di
express
em
e
mn
almost
sarscov
antigen
detect
area
upon
immunohistochem
analysi
infiltr
lymphocyt
shown
posit
tcell
first
evid
induct
protect
immun
sarscov
associ
mark
infiltr
cell
sarscov
infect
site
abl
detect
sarscov
sspecif
cell
spleen
immun
mice
elispot
thu
result
suggest
cell
induct
mice
immun
rdissarsem
rdissarsemn
might
provid
addit
help
complet
elimin
sarscov
lung
note
weingartl
et
al
report
low
level
neutral
antibodi
respons
ferret
mustela
putoriu
furo
immun
recombin
mva
express
sarscov
protein
also
show
rapid
vigor
neutral
antibodi
respons
immun
ferret
compar
control
anim
challeng
sarscov
howev
sarscov
infect
spread
immun
ferret
prevent
moreov
upon
infect
sarscov
strong
inflammatori
respons
note
ferret
immun
either
recombin
mva
express
sarscov
n
protein
suggest
vaccin
recombin
mva
express
sarscov
n
protein
may
case
lead
enhanc
patholog
sarscov
infect
czub
et
al
weingartl
et
al
also
report
antibodi
neutral
human
sarscov
enhanc
entri
mediat
civet
viru
suggest
possibl
kind
vaccin
might
enhanc
viral
infect
yang
et
al
although
observ
patholog
rdisimmun
mice
viru
challeng
potenti
widespread
tissu
damag
follow
administr
sarscov
protein
care
investig
addit
studi
requir
clarifi
whether
recruit
tcell
inde
play
import
role
clearanc
sarscov
site
infect
studi
construct
rdi
contain
gene
encod
four
structur
protein
sarscov
individu
simultan
express
intranas
subcutan
inocul
balbc
mice
rdi
express
protein
without
structur
protein
elicit
high
level
neutral
antibodi
sarscov
protect
immun
lung
mice
intranas
challeng
furthermor
cellular
mucos
immun
sarscov
structur
protein
also
induc
follow
administr
rdi
therefor
replicationdefici
di
strain
feasibl
safe
effect
sar
vaccin
vector
cell
cef
cell
vero
cell
grown
dulbecco
modifi
essenti
medium
dmem
supplement
fetal
bovin
serum
fc
penicillinstreptomycin
lglutamin
gibco
brllife
technolog
gaithersburg
md
murin
b
cell
maintain
supplement
fc
lglutamin
antibiot
plasmid
dna
construct
dna
prepar
cdna
encod
sarscov
structur
protein
gener
revers
transcript
sarscov
access
use
superscriptii
invitrogen
corp
carlsbad
ca
follow
amplif
use
expand
high
fidel
pcr
system
roch
diagnost
describ
previous
ohnishi
et
al
dna
fragment
encod
e
n
protein
clone
vaccinia
viru
transfer
vector
also
harbor
e
coli
xanthineguanin
phosphoribosyltransferas
control
vaccinia
viru
promot
clone
site
pucdi
ishii
et
al
gener
pdissars
pdissarsm
pdissarsn
pdissarss
respect
construct
transfer
vector
gener
rdi
express
em
em
e
mn
dna
fragment
encod
n
protein
control
promot
vaccinia
viru
wyatt
et
al
insert
pdissars
smai
noti
saci
site
respect
thu
gener
pdissarsem
pdissarsem
pdissarsemn
fig
plasmid
express
driven
promot
construct
use
pefbosbst
yoshizawa
et
al
design
pefsbst
recombin
form
di
obtain
hypoxanthineguanin
phosphoribosyltransferas
select
falkner
moss
monolay
cef
cell
plate
preincub
dmem
contain
fc
micopheno
acid
mpa
xanthin
hypoxanthin
infect
perform
onto
cef
cell
grown
cm
dish
di
multipl
infect
moi
transfect
perform
use
di
transfer
vector
lipofectamin
gibco
brllife
technolog
rdi
express
sarscov
structur
protein
select
follow
four
consecut
round
plaqu
purif
cef
cell
plate
preincub
dmem
contain
fc
mpa
xanthin
hypoxanthin
result
rdi
express
sarscov
structur
protein
design
rdissars
rdissarsm
rdissarsn
rdissarss
rdissarsem
rdissarsem
rdissarsemn
respect
subsequ
maintain
cef
cell
use
studi
cef
cell
infect
rdi
construct
harbor
orf
sarscov
structur
protein
fraction
sdspage
reduc
condit
purifi
sarscov
virion
use
posit
control
protein
transfer
immobilonp
pvdf
membran
millipor
bedford
incub
monoclon
antibodi
n
protein
ohnishi
et
al
polyclon
antibodi
protein
mizutani
et
al
wash
membran
react
hrpconjug
fab
fragment
antimous
rabbit
igg
h
l
santa
cruz
biotechnolog
santa
cruz
ca
follow
visual
band
use
chemiluminesc
reagent
pierc
rockford
il
cef
cell
infect
rdi
express
sarscov
structur
protein
h
incub
cell
wash
pb
fix
paraformaldehyd
pb
min
room
temperatur
fix
cell
permeabil
triton
min
room
temperatur
block
nonfat
milk
solut
block
ace
yukijirushi
co
tokyo
japan
cell
incub
polyclon
antibodi
n
protein
mizutani
et
al
min
cell
incub
fluorescein
isothiocyan
fitc
conjug
goat
antirabbit
igg
tago
burlingam
ca
dilut
pb
detect
sarscov
n
protein
analyz
subcellular
local
sar
structur
protein
monoclon
antibodi
bd
bioscienc
mississauga
canada
rhodamineconjug
goat
antimous
igg
tago
use
stain
golgi
apparatu
anim
studi
carri
protocol
approv
anim
care
use
committe
nation
institut
infecti
diseas
japan
fiveto
femal
balbc
mice
purchas
japan
slc
hamamatsu
japan
immun
pfu
rdi
either
subcutan
sc
intranas
week
ident
titer
recombin
viru
readminist
one
week
later
mice
intranas
challeng
tcid
sarscov
salin
previous
describ
three
day
later
serum
nasal
wash
fluid
bronchoalveolar
wash
fluid
collect
measur
viral
titer
antibodi
sarscov
mice
sacrif
anesthesia
chloroform
iga
igg
titer
sarscov
determin
elisa
previous
describ
takasuka
et
al
briefli
microtit
plate
dynatech
chantili
va
coat
overnight
sarscovinfect
mockinfect
vero
cell
lysat
sampl
previous
treat
follow
uvinactiv
plate
block
ova
tween
incub
serial
dilut
sera
h
room
temperatur
plate
incub
either
peroxidaseconjug
antimous
igg
zyme
south
san
francisco
ca
iga
southern
biotechnolog
birmingham
al
antibodi
plate
wash
three
time
pbstween
step
substrat
mixtur
ophenylenediamin
zyme
hydrogen
peroxid
ad
well
absorb
well
read
nm
use
model
micropl
reader
biorad
hercul
ca
provid
standard
igg
detect
serum
obtain
hyperimmun
mous
valu
elisa
unitsml
standard
serum
around
three
everi
assay
sarscovspecif
igg
titer
calcul
subtract
optic
densiti
well
coat
noninfect
cell
lysat
optic
densiti
well
coat
virusinfect
cell
lysat
posit
control
induc
sarscovspecif
iga
mice
immun
intranas
uvinactiv
purifi
sarscov
togeth
poli
c
ichinoh
et
al
sera
collect
vaccin
mice
inactiv
incub
min
serial
dilut
mice
sera
fivefold
incub
tcid
sarscov
h
mixtur
ad
vero
cell
cultur
grown
confluenc
microtit
plate
h
cell
fix
formaldehyd
stain
crystal
violet
visual
cytopath
effect
viru
storch
neutral
antibodi
titer
express
minim
dilut
sera
capabl
inhibit
viral
cytopath
effect
cln
aln
spleen
obtain
mice
week
third
vaccin
follow
prepar
singl
cell
suspens
cell
purifi
use
pan
cell
isol
kit
magnet
cell
sort
system
mac
miltenyi
biotec
bergisch
gladbach
germani
prepar
apc
normal
balb
c
mous
splenocyt
deplet
cell
mac
irradi
cgi
purifi
cell
cultur
apc
presenc
absenc
uvirradi
purifi
sarscov
virion
four
day
cultiv
cytokin
concentr
within
cultur
supernat
measur
flow
cytometri
use
mous
cytokin
cytometr
bead
array
kit
becton
dickinson
san
jose
ca
murin
b
cell
transfect
either
pefsbst
pefbosbst
electropor
v
use
genepuls
biorad
laboratori
hercul
ca
select
use
blasticidin
invitrogen
follow
limit
dilut
clone
clone
obtain
detect
protein
express
cell
cell
stain
biotinyl
anti
monoclon
antibodi
ohnishi
et
al
control
antibodi
follow
incub
apcstreptavidin
ebiosci
inc
san
diego
ca
analyz
facscalibur
bd
bioscienc
use
cell
quest
ii
program
propidium
iodid
use
exclud
dead
cell
data
reanalyz
depict
use
flowjo
softwar
tree
star
inc
san
carlo
ca
spleen
cell
mice
immun
rdissarsn
rdissarsemn
separ
use
mac
system
miltenyi
biotec
auburn
ca
enrich
cell
cell
fraction
cell
partial
remov
use
mabcoat
magnet
bead
miltenyi
biotec
procedur
reduc
number
cell
less
one
third
overlap
peptid
cover
whole
n
sequenc
sarscov
obtain
sigmaaldrich
japan
peptid
correspond
bind
region
protein
select
produc
base
websit
program
syfpeithi
http
syfpeithid
murin
b
cell
irradi
cgi
use
apc
peptid
correspond
either
n
protein
experi
cell
stabli
transfect
pef
empti
vector
pefbo
use
elispot
assay
perform
accord
method
outlin
diaclon
research
besancon
franc
brief
flatbottom
plate
maxisoap
nunc
plate
nunc
rochest
ny
coat
captur
antibodi
one
h
plate
wash
pb
contain
tween
pbst
block
pb
contain
bovin
serum
albumin
overnight
freshli
isol
splenic
cell
apc
ad
plate
presenc
absenc
n
peptid
incub
h
co
plate
follow
lysi
icecold
deioniz
water
plate
wash
biotinyl
detect
antibodi
ad
plate
incub
h
plate
wash
three
time
pbst
streptavidinalkalin
phosphataseconjug
antibiotin
immunoglobulin
g
solut
ad
follow
incub
h
wash
pbst
substrat
mix
ad
plate
allow
develop
h
well
imag
number
spotform
cell
sfc
count
use
ks
elispot
compact
system
carl
zeiss
jena
germani
lung
tissu
mice
fix
buffer
formalin
embed
paraffin
paraffin
block
section
stain
hematoxylin
eosin
h
e
sarscov
antigen
immunohistochem
detect
use
labeledstreptoavidinbiotin
complex
stain
system
dakocytom
co
japan
kyoto
japan
rabbit
polyclon
antibodi
rais
uvinactiv
purifi
sarscov
use
primari
antibodi
catalyz
signal
amplif
method
dako
also
use
detect
sarscov
antigen
enhanc
sensit
lung
section
mice
vaccin
rdissarsemn
infect
sar
cov
stain
antibodi
santa
cruz
biotechnolog
also
like
thank
ms
mami
matsuda
ms
makiko
yahata
ms
sayaka
yoshizaki
ms
chikako
sato
mr
masayuki
ishig
ms
yuko
sato
ms
aya
harashima
excel
technic
support
work
support
heath
labour
scienc
research
grant
ministri
health
labour
welfar
japan
new
energi
industri
technolog
develop
organ
nedo
japan
